drugset

drugset / Trial / NCT05714891

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

NCT05714891 ↗

Phase 2 Active not recruiting 4 enrolled Canadian Cancer Trials Group Novartis · collab

NaSingle-groupOpen-labelTreatment

Summary

This study is being done to answer the following question: What are the effects of new treatments on non-small cell lung cancer before surgery?

Timeline

Start: 2023-09-15
Primary completion: 2026-08-31
Completion: 2028-03-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Opnurasib	Small molecule	—	—

Indications